Niacin clinical trials
Also written Niaspan, Nicotinic acid and Niacor.
How each study uses Niacin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Niacin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 24 Jul 1957 · WAMPOCAP · NDA 011073 (FDA, Drugs@FDA)
- European Union
- 3 Jul 2008 · Tredaptive · EMEA/H/C/000889 (EMA; in a combination; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- ABT-919
- 1
Studies by the year they started
99 studies that test it; most in 2010 (9)
| Year | Studies |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 6 |
| 2004 | 5 |
| 2005 | 5 |
| 2006 | 6 |
| 2007 | 6 |
| 2008 | 6 |
| 2009 | 6 |
| 2010 | 9 |
| 2011 | 6 |
| 2012 | 6 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 19 · Other 84
Merck Sharp & Dohme LLC (7) · Université de Sherbrooke (5) · University of Pennsylvania (4) · Kos Pharmaceuticals (4) · Sanofi (3) · University of Washington (3) · Mayo Clinic (2) · Organon and Co (2)
Often tested with
Tested in the same studies.
MK-0524 (14) · Fenofibrate (9) · Niacinamide (7) · Ezetimibe (6) · Simvastatin (6) · Atorvastatin (6) · Lovastatin (6) · Alirocumab (3)
Related medicines
As reviewed, each with the page that says it.
- One of Hypolipidemic Agents source
- One of Vitamin B Complex source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 5
Studies that test Niacin.
- Dec 20265-HT2A Agonist Psilocybin in the Treatment of Tobacco Use DisorderPhase 2 · Johns Hopkins University
- Dec 2026Nicotinic Acid for the Treatment of Alzheimer's DiseasePhase 1/2 · Indiana University
- Apr 2027Regulation of Endogenous Glucose Production by Central KATP ChannelsPhase 2 · Albert Einstein College of Medicine
- May 2027A Study of Niacin RegulationEarly Phase 1 · Mayo Clinic
- Jul 2027Pathways of Eicosanoid MetabolismEarly Phase 1 · Vanderbilt University
Studies
Open first, then newest update. How each study uses Niacin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 103
- Niacin and Selenium Combination Therapy in Patients With Septic ShockNot yet recruitingPhase 2Seoul National University HospitalNCT07940933Written as NiacinHow we know
- Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.RecruitingNot applicableUniversité de SherbrookeNCT06843148Written as Niacin (250mg)How we know
- Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer PatientsRecruitingPhase 1Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNCT07119996Written as Tislelizumab, Cisplatin, Gemcitabine and Vitamin B3How we know
- 5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use DisorderRecruitingPhase 2Johns Hopkins UniversityNCT05452772Written as NiacinHow we know
- Pathways of Eicosanoid MetabolismEnrolling by invitationEarly Phase 1Vanderbilt UniversityNCT04464070Written as niacinHow we know
- Regulation of Endogenous Glucose Production by Central KATP ChannelsRecruitingPhase 2Albert Einstein College of MedicineNCT03540758Written as Nicotinic acidHow we know
- A Study of Niacin RegulationRecruitingEarly Phase 1Mayo ClinicNCT06175403Written as NiacinHow we know
- Nicotinic Acid for the Treatment of Alzheimer's DiseaseRecruitingPhase 1/2Indiana UniversityNCT06582706Written as Extended Release NiacinHow we know
- Adipose Tissue Storage in the Rapid Remission of Hepatic and Cardiac Metabolic Dysfunction After Bariatric SurgeryRecruitingNot applicableUniversité de SherbrookeNCT05934409Written as Nicotinic AcidHow we know
- The Kidney's Response to Exercise in Heat, and the Impact of Vitamin B3 on This ResponseRecruitingEarly Phase 1Beth Israel Deaconess Medical CenterNCT06983730Written as Vitamin B3How we know
- Study the Effect of Niacin on Lipoprotein (a) Concentration and Hyperphosphatemia in Hemodialysis PatientsEnrolling by invitationPhase 2/3Al-Azhar UniversityNCT06406140Written as Niacin tablets 500 mgHow we know
- The Impact of Tredaptive on Flow-Mediated Dilation in Cardiac PatientsTerminatedPhase 4Sheba Medical CenterNCT01052311Written as TredaptiveHow we know
- Study of Niacin in GlioblastomaActive, not recruitingPhase 1/2AHS Cancer Control AlbertaNCT04677049Written as Niacin CRTHow we know
- Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke RecoveryTerminatedPhase 2Henry Ford Health SystemNCT00796887Written as Extended-Release NiacinHow we know
- Brown Adipose Tissue Metabolism in Type 2 DiabetesCompletedNot applicableUniversité de SherbrookeNCT05092945Written as Oral Nicotinic acidHow we know
- Effect of Nicotinic Acid as Add on Therapy in Patients Receiving β Blocker for Prophylaxis of Moderate to Severe MigraineCompletedPhase 2Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshNCT05846373Written as Nicotinic Acid 500 MG Extended Release Oral TabletHow we know
- Glycogen and AppetiteCompletedNot applicableUniversity of BathNCT05417659Written as Exercise plus niacinHow we know
- Effects of Niacin Therapy on Lipoprotein Composition and FunctionCompletedNot applicableNational Heart, Lung, and Blood Institute (NHLBI)NCT02322203Written as Niacin Extended ReleaseHow we know
- Low Dose Niacin (Vitamin B3) for Parkinson's DiseaseTerminatedNot applicableVA Office of Research and DevelopmentNCT03808961Written as NiacinHow we know
- Postprandial Fatty Acid Metabolism in the Natural History of Type 2 Diabetes (T2D)CompletedNot applicableUniversité de SherbrookeNCT02808182Written as Nicotinic acidHow we know
See all 103 studies that test Niacin →
Given beside what is tested · 15 — Niacin is usual care or a partner of the new treatment
- Biosynthesis of PGD2 in VivoCompletedNot applicableUniversity of PennsylvaniaNCT01275300Written as NiacinHow we know
- Visual Surround Suppression and Perceptual Expectation Under PsilocybinTerminatedPhase 1University of MinnesotaNCT04424225Written as NiacinHow we know
- PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)TerminatedPhase 1Karyopharm Therapeutics IncNCT02702492Written as Niacin ERHow we know
- A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's LymphomaTerminatedPhase 1Antengene Therapeutics LimitedNCT04281420Written as ATG-019 + Niacin ERHow we know
- Psilocybin Cancer Anxiety StudyCompletedEarly Phase 1NYU Langone HealthNCT00957359Written as NiacinHow we know
- A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED)CompletedPhase 1Merck Sharp & Dohme LLCNCT00769132Written as Comparator: niacin + laropiprantHow we know
- Olive Oil and Nampt on Postprandial Inflammation and Atherosclerosis in the Setting of Metabolic SyndromeCompletedNot applicableNational Research Council, SpainNCT02061267Written as NiacinHow we know
- Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDLCompletedPhase 2University of PennsylvaniaNCT00300365Written as Niacin ERHow we know
- An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032)CompletedPhase 2Merck Sharp & Dohme LLCNCT00111891Written as niacin (+) laropiprantHow we know
- Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility StudyCompletedPhase 2University of PennsylvaniaNCT00728910Written as ER NiacinHow we know
- Effect of MK0524A on Cholesterol Levels (0524A-048)CompletedPhase 3Merck Sharp & Dohme LLCNCT00536510Written as laropiprant/niacin (MK0524A)How we know
- Lipid Efficacy/Tolerability Study (0524A-020)CompletedPhase 3Merck Sharp & Dohme LLCNCT00269204Written as niacin (+) laropiprantHow we know
- Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)CompletedPhase 3Merck Sharp & Dohme LLCNCT00479388Written as niacin (+) laropiprantHow we know
- Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVECompletedPhase 3University of OxfordNCT00461630Written as ER niacin/laropiprantHow we know
- Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With DyslipidemiaCompletedPhase 3AbbottNCT00626392Written as niacin extended-release (NER)How we know
As the comparator · 9 — what is tested is compared with Niacin
- Psilocybin Therapy in Advanced CancerRecruitingPhase 2/3NYU Langone HealthNCT05398484Written as Niacin 100mgHow we know
- Comparisons of NAD Precursors for Neuroenhancement in Glaucoma PatientsRecruitingPhase 2Christopher Kai Shun LeungNCT06991712Written as Nicotinic AcidHow we know
- MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress DisorderRecruitingPhase 2University of SydneyNCT05709353Written as NiacinHow we know
- A Study of Psilocybin for Major Depressive Disorder (MDD)CompletedPhase 2Usona InstituteNCT03866174Written as NiacinHow we know
- The Effect of Psilocybin on MDD Symptom Severity and Synaptic DensityCompletedPhase 2Section for Affective Disorders; Northern Stockholm PsychiatryNCT04630964Written as NiacinHow we know
- Study to Test GSK256073 in Patients With DyslipidemiaCompletedPhase 2GlaxoSmithKlineNCT00903617Written as NiaspanHow we know
- A Study to Evaluate the Effects of Extended Release (ER) Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites in Subjects With High Cholesterol (0524A-075)(COMPLETED)CompletedPhase 1Merck Sharp & Dohme LLCNCT00769132Written as Comparator: niacin + laropiprantHow we know
- Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)CompletedPhase 4SanofiNCT02642159Written as Nicotinic acidHow we know
- Comparison of TRIA-662 500 mg and Niaspan 1000 mg in Healthy Male and Female Volunteers Under Fed ConditionsCompletedPhase 1Cortria CorporationNCT01809301Written as NiaspanHow we know
What changed recently
From the registry's own updates since Oct 20, 2026.
Newly registered1
- Niacin and Selenium Combination Therapy in Patients With Septic ShockNov 17, 2026NCT07940933
Codes
What other systems call Niacin · ClinicalTrials.gg INT007883
- MeSH (NLM) D009525NiacinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 2679MF687ANIACINConfirmed FDA, NLM
- RxNorm 7393One source FDA
- NCI Thesaurus C689NiacinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D009525 | Niacin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 2679MF687A | NIACIN | Confirmed FDA, NLM |
| RxNorm | 7393 | — | One source FDA |
| NCI Thesaurus | C689 | Niacin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.